ArticleCancers2025
Targeting CXCR6 Disrupts β-Catenin Signaling and Enhances Sorafenib Response in Hepatocellular Carcinoma.
Morgan Reeves et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancers2025
Morgan Reeves et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.